HomeHealth Disclosure of Share Capital and Voting

Disclosure of Share Capital and Voting

by globenewswire
0 comment 1 minutes read

Disclosure of Share Capital and Voting Rights Outstanding
as of October 31, 2023

(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Charenton-le-Pont, France (November 13, 2023 – 6:30 pm) – As of October 31, 2023, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.

  October 31, 2023 Shares outstanding 453,623,5011 Number of real voting rights (excluding treasury shares) 451,245,329 Theoretical number of voting rights (including treasury shares) 453,623,501

It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained in article 23 of EssilorLuxottica’s by-laws2.

For further information, please consult the Prospectus which received Visa No. 18-460 from the AMF on September 28, 2018 and its Securities Note Supplement which received Visa No. 18-494 from the AMF on October 23, 2018, available on the website www.essilorluxottica.com.

1Including 11,036 shares delivered but not yet registered as of October 31, 2023.
2EssilorLuxottica’s by-laws are available on the Company’s website under the section Governance / Publications.

 

DOWNLOAD THE PRESS RELEASE

You may also like

Magzter-Logo
Readwhere-Logo
Google-Play-Books-Logo
Google-Play-Logo

Life Care (Lifecarenews) is a Fortnightly Magazine, you can read article, Business information, News about Health, Entertainment, Sports, Movies, Technology, etc. for more read to click here

Edtior's Picks

Latest Articles

©2015-2023-All Right Reserved. Designed and Developed by Life Care News

LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283

Life Care News
A Hope Of True Information

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.AcceptRead More